Publications by authors named "M Stanislavchuk"

Claim this Profile
A
A phase 3, randomized, double-blind, active-controlled clinical trial to compare BAT1806/BIIB800, a tocilizumab biosimilar, with tocilizumab reference product in participants with moderate-to-severe rheumatoid arthritis with inadequate response to methotrexate: treatment period 2 analysis (week 24 to week 48).
Xiaomei Leng, Piotr Leszczyński, Slawomir Jeka, Shengyun Liu, Huaxiang Liu, Mykola Stanislavchuk

Arthritis Res Ther· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Level of glial cell derived neurotrophic factor in the blood plasma of rheumatoid arthritis patients and its relationship with alexithymia.
Yevhenii Shalkovskyi, Mykola Stanislavchuk

Reumatologia· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparing tocilizumab biosimilar BAT1806/BIIB800 with reference tocilizumab in patients with moderate-to-severe rheumatoid arthritis with an inadequate response to methotrexate: a phase 3, randomised, multicentre, double-blind, active-controlled clinical trial.
Xiaomei Leng, Piotr Leszczyński, Sławomir Jeka, Sheng-Yun Liu, Huaxiang Liu, Mykola Stanislavchuk

Lancet Rheumatol· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical characteristics of ankylosing spondylitis patients depending on neuropathic pain.
Ivan Kedyk, Mykola Stanislavchuk

Reumatologia· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparative characteristics of ACR 1990, mACR 2010, ACR 2016 and AAPT 2019 criteria for diagnosing fibromyalgia in patients with ankylosing spondylitis.
Iryna Shapoval, Mykola Stanislavchuk

Rheumatol Int· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis